MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Priorities of PD patients for treatment of cognitive-driven ADL impairment

    I. Liepelt-Scarfone, M. Bentele, S. Becker, C. Altmann, E. Schaeffer, K. Michaelis, S. Solbrig, K. Brockmann (Tübingen, Germany)

    Objective: To define cognitive-driven impairments in activities of daily living (ADL) with high priority for rehabilitation ranked by Parkinson’s disease (PD) patients. Background: Impairments in…
  • 2022 International Congress

    Motor decision-making in Parkinson’s disease

    L. Avanzino, B. Berret, E. Pelosin, M. Bove, T. Pozzo, A. Bisio (Genoa, Italy)

    Objective: The aim of this study is to test motor decision-making ability in Parkinson's disease (PD) in conditions with different biomechanical properties and levels of…
  • 2022 International Congress

    The position of students of communication sciences and disorders department at Ono Academic College regarding telepractice vs. face-to-face internship experience in speech and swallowing therapy for patients with movement disorders.

    Y. Manor, D. Shpunt, A. Zait, O. Abramov, D. Biteulin Maharat, A. Avraham, A. Twik-Klein, I. Feldman, T. Gurevich, H. Putter Katz (Tel Aviv-Yafo, Israel)

    Objective: To assess the position of students from the communication sciences and disorders department (CSD) regarding telepractice vs. face-to-face internship in speech and swallowing therapy…
  • 2022 International Congress

    Long-term safety of continuous levodopa/carbidopa infusion with ND0612: Data from patients who continued past one year in the BeyoND study

    S. Isaacson, N. Giladi, F. Stocchi, L. Salin, N. Vostokova, W. Poewe (Boca Raton, USA)

    Objective: To report long-term safety and tolerability data from the ongoing BeyoND study (NCT02726386) for patients who continued treatment past the one-year primary endpoint. Background:…
  • 2022 International Congress

    Plasma p-Tau181 and p-Tau231 in Parkinson’s Disease

    MC. Gonzalez, NJ. Ashton, A. Pilitto, A. Padovani, B. Fernandes Gomes, DA. Tovar-Rios, F. Blanc, A. Lemstra, C. Paquet, C. Abdelnour, M. Boada, L. Bonanni, R. Vandenberghe, K. Blennow, H. Zetterberg, D. Aarsland (Stavanger, Norway)

    Objective: To explore whether plasma phosphorylated tau (p-Tau) 181 and p-Tau231 levels are associated with cognition in a Parkinson’s Disease (PD) cohort. Background: We recently…
  • 2022 International Congress

    Classical Machine Learning approaches to automate tremor detection from electrophysiological data

    A. Vishnoi, R. Anandapadmanabhan, D. Biswas, A. Srivastava, D. Joshi, A. Mahabal (New Delhi, India)

    Objective: To detect tremor syndromes from electrophysiological signatures using classical machine learning techniques. Background: Electromyographic recordings combined with accelerometry data are widely used to measure…
  • 2022 International Congress

    A facilitated self-management toolkit for people with Parkinson’s disease: A feasibility study of ‘Live Well with Parkinson’s

    M. Armstrong, T. Rookes, A. Schrag, K. Walters (London, United Kingdom)

    Objective: To assess the feasibility and acceptability of a theory and evidence-based digital facilitated self-management toolkit for people with Parkinson’s: ‘Live Well with Parkinson’s’. Background:…
  • 2022 International Congress

    Inflammatory microglial and astroglial phenotype associated with pathological alpha-synuclein inclusions in the substantia nigra

    A. Stoll, M. Bensky, J. Patterson, C. Kemp, K. Steece-Collier, M. Hore, K. Luk, C. Sortwell (Grand Rapids, USA)

    Objective: To characterize neuroinflammatory gene expression in microglia and astrocytes associated with early alpha-synuclein (a-syn) inclusion formation. Background: Parkinson’s disease (PD) is characterized by alpha-synuclein…
  • 2022 International Congress

    Isolated craniocervical dystonia without neuropsychiatric manifestations associated with NMDA-receptor antibodies

    S. Waller, L. Williams, A. Lee, MW. Lin, H. Morales-Briceno, V. Fung (Westmead, Australia)

    Objective: N-methyl-D-aspartate receptor (NMDAR) encephalitis classically spans neuropsychiatric disturbance, autonomic dysfunction and salient movement disorders. Attenuated presentations are increasingly recognised; however, presentations with an isolated…
  • 2022 International Congress

    Alterations in neuron-derived exosomal cargo in Parkinson Disease

    V. Gorgogietas, IB. Boussaad, F. Borgmann, M. Mittelbronn, R. Krueger (Esch-sur-Alzette, Luxembourg)

    Objective: The main objectives are 1) the confirmation of exosome isolation, based on iPSC-derived midbrain neuron model, 2) the identification of α-synuclein cargo of PD-patient…
  • « Previous Page
  • 1
  • …
  • 563
  • 564
  • 565
  • 566
  • 567
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley